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ABSTRACT
Miniaturized integrated DNA analysis systems
have largely been based on a multi-chamber design
with microfluidic control to process the sample
sequentially from one module to another. This
microchip design in connection with optics involved
hinders the deployment of this technology for point-
of-care applications. In this work, we demonstrate
the implementation of sample preparation, DNA
amplification, and electrochemical detection in a
single silicon and glass-based microchamber and
its application for the multiplexed detection of
Escherichia coli and Bacillus subtilis cells. The
microdevice has a thin-film heater and temperature
sensor patterned on the silicon substrate. An array
of indium tin oxide (ITO) electrodes was constructed
within the microchamber as the transduction ele-
ment. Oligonucleotide probes specific to the target
amplicons are individually positioned at each
ITO surface by electrochemical copolymerization of
pyrrole and pyrrole probe conjugate. These immo-
bilized probes were stable to the thermal cycling
process and were highly selective. The DNA-based
identification of the two model pathogens involved
a number of steps including a thermal lysis step,
magnetic particle-based isolation of the target
genomes, asymmetric PCR, and electrochemical
sequence-specific detection using silver-enhanced
gold nanoparticles. The microchamber platform
described here offers a cost-effective and sample-
to-answer technology for on-site monitoring of
multiple pathogens.
INTRODUCTION
Decentralized medical testing plays a vital role in today’s
health care system. The blood glucose meter, which was
the ﬁrst commercial handheld device for medical diagnostics
and developed three decades ago, is by far one of the most
successful examples in point-of-care testing (POCT). In the
years to come, driven by the ever-growing threats from
emerging infectious diseases (e.g. avian ﬂu and severe
acute respiratory syndrome), the development of small-size
instruments for on-the-spot pathogen detection is expected
to be an important segment of the POCT market. This trend
has already commenced with a few companies having
launched self-test products for hepatitis and human immun-
odeﬁciency virus detection based on antibody–antigen
interactions (e.g. OraSure Technologies and ACON Laborat-
ories). These systems give a visual readout indicating the
presence or absence of the target virus in  15 min. One of
the main shortcomings of these immunological techniques
is their limited sensitivity. To address this issue, there have
been signiﬁcant efforts to develop nucleic acid (NA)-based
analyzers (1–3). The miniaturization of NA analytical plat-
forms has many advantages over the conventional bench-top
counterparts. These include low sample/reagent consumption
(volume of micro- down to picoliter) as well as short assay
time (minutes rather than days). Most importantly, they per-
mit the integration of a number of functions including sample
preparation, target ampliﬁcation, and product detection, thus
enabling a fully automated operation that can be used by
untrained individuals.
To date, several integrated NA-based analytical systems
have been commercialized [http://www.cepheid.com/Sites/
cepheid/content.cfm?id¼158 (GeneXpert from Cepheid),
http://www.gen-probe.com/prod_serv/inst_dts.asp (Direct
Tube Sampling Systems from Gen-Probe), http://www.
idahotech.com/razor/index.html (RAZOR from Idaho
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shtml (Liat Analyzer from IQuum)]. Despite their wide use
in clinical/central laboratories, their application for on-site
pathogen monitoring on a routine basis is still limited due
to the large footprint and high instrument cost (mainly the
complex optics). A promising alternative would be
the inherently simple and lost-cost electrochemical method.
Over the past decade, despite a great deal of work having
been carried out on electrochemical sequence-speciﬁc NA
sensing (4–6), little work has been undertaken on the integra-
tion of these with upstream functionalities. In 2004, Liu et al.
(7) successfully demonstrated a fully integrated biochip for
cell isolation and lysis, target ampliﬁcation, as well as
electrochemical amplicon detection. One relevant feature
of their approach is the incorporation of on-chip mixers,
valves, and pumps in a self-contained device. However, the
design and fabrication of the chip involves many complicated
steps, which limits its practical application.
In a previous study, our group demonstrated a proof-of-
concept experiment that both DNA ampliﬁcation by the
PCR and sequence-speciﬁc electrochemical amplicon detec-
tion could be done in a single microchamber (8), in contrast
to the commonly used device which involved multi-chambers
with complex microﬂuidic control elements (9). This micro-
device had an 8 mL reaction chamber etched in a silicon sub-
strate with a thin-ﬁlm heater and temperature sensor patterned
on top for rapid thermal cycling. An oligonucleotide capture
probe-modiﬁed detection electrode was placed on a glass
substrate used to seal the microchamber. To develop this pro-
totype device into practical use, sample preparation function-
ality as well as the ability to perform multiplexed analysis
would need to be addressed.
In this work, we present a complete DNA-based assay in
a single silicon–glass microchamber for multiple pathogen
detection. A model system of E.coli and B.subtilis was
used. The assay involves the following steps: (i) sample pre-
paration using thermal cell lysis and magnetic particle-based
target genome isolation; (ii) target DNA ampliﬁcation by the
PCR; (iii) hybridization of the amplicons to their comple-
mentary oligonucleotide capture probes immobilized onto
Figure 1. Photographs showing the silicon–glass microchip. (A) Upper left: top view of the silicon chip showing the fluidic holes along with thin-film platinum
heater and temperature sensors; lower left: bottom view of the silicon chip showing the 8 mL reaction chamber and the through-hole for fluid introduction;
right panel: glass chip with patterned indium tin oxide working electrodes. (B) The assembled silicon–glass microchip with pipet tips glued to the fluidic holes.
(C) Electrical connection of the contact pins to the silicon–glass microchip housed in a plexiglass holder.
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cal transduction of the recognition event via gold nanoparti-
cles with signal ampliﬁcation using electrocatalytic silver
deposition (10). An issue of importance much needed to be
addressed was the compatibility of all the materials and
processing steps. In particular, the chemistry used for the
site-speciﬁc probe immobilization together with that of the
magnetic particles used for genome isolation should be
PCR-compatible.
MATERIALS AND METHODS
Reagents and instrumentation
Oligonucleotides and PCR reagents were obtained from
Invitrogen (Carlsbad, CA, USA), unless otherwise stated.
Other chemicals were purchased from Sigma–Aldrich
(St. Louis, MO, USA). Electrochemical measurements were
performed using a VMP multichannel potentiostat (Princeton
Applied Research, Oak Ridge, TN, USA) controlled by
EC-Lab software (version 6.70, Bio-Logic Science Instru-
ments, Claix, France). The thermal control system for the
PCR consisted of a data acquisition card (PCI-MIO-16E-1,
National Instruments, Austin, TX, USA) along with a signal
conditioning board (SC-2042-RTD, National Instruments)
connected to the temperature sensors. A digital feedback
proportional-integral-derivative (PID) control algorithm was
implemented in LabVIEW software (National Instruments)
to control voltage supply to the heater from a power source
(HP6629A, Hewlett-Packard, Rockville, MD, USA).
Silicon–glass microchip fabrication
The silicon chip (thickness of 400 mm) had two ﬂuid injection
holes (top side, diameter of 500 mm, depth of 100 mm) and
a chamber (bottom side, length and width of 5 mm, depth
of 325 mm) etched by the inductively coupled plasma/deep
reactive ion etching (ICP/DRIE) process, see Figure 1A
(left panels). Thin-ﬁlm platinum (100 nm) was patterned on
top of the silicon substrate as heater and temperature sensors
(Figure 1A, upper left). The glass chip had platinum pseudo-
reference and counter electrodes (thickness of 100 nm) as
well as four working electrodes made of indium tin oxide
(ITO) (thickness of 100 nm), see right panel of Figure 1A.
Ultra-violet curing optical cement (Type UV-69, Summers
Optical, Hatﬁeld, PA, USA) was used to bond the silicon
and glass chips, the curing procedure was in accordance
with the manufacturer’s instruction. Pipet tips were glued to
the ﬂuid injection holes with epoxy (Figure 1B).
Oligonucleotide detection capture probe
immobilization
An oligonucleotide capture probe speciﬁc for E.coli amplicon
[pyrrole-50-ACAACACGTTTAGCCTGACC-30 (pyrrole-EC),
Apibio, France] was ﬁrst electrochemically polymerized onto
two of the four ITO working electrodes. A mixture of 60 mM
pyrrole, 20 mM pyrrole-EC, and 0.1 M LiClO4 was introduced
into the microchamber, followed by a cyclic voltammetric
scan of the two electrodes between  0.5 and +0.65 V at a
scan rate of 50 mV/s for three times. The microchamber
was then washed with deionized water and dried with
nitrogen gas. The same procedure was repeated for the
other two ITO working electrodes, except an oligonucleotide
capture probe speciﬁc for B.subtilis amplicon [pyrrole-
50-CCTACGGGAGGCAGCAG-30 (pyrrole-BS), Apibio,
France] was used.
Preparation of magnetic particles for genome isolation
Ten microliters of avidin-coated magnetic particles (3.0 mm,
VMS-30-10, Spherotech, Libertyville, IL, USA) were washed
with an equal volume of saline/sodium citrate buffer (SSC,
150 mM NaCl/15 mM sodium citrate, pH 7.0). After
centrifugation and pipetting, the supernatant was removed
and the magnetic particles were incubated with 10 mLo f
10 nM biotinylated genome capture probe overnight at
room temperature. Oligonucleotide sequence of the genome
capture probe for E.coli was 50-biotin-GACAAGAAAATC-
TCCAACATCC-30 while that for B.subtilis was 50-biotin-
CCAGTTTCCAATGACCCTCCCC-30. The capture probe
functionalized magnetic particles were ﬁnally washed with
10 mL of the SSC buffer, resuspended in 10 mL of the SSC
buffer, and stored at 4 C.
Figure 2. (A–D) A schematic diagram showing the electrode-by-electrode
capture probe immobilization via electrochemical copolymerization of
pyrrole and pyrrole oligonucleotide. The polymerization solution contained
60 mM pyrrole, 20 mM pyrrole probe, and 0.1 M LiClO4 and the electrode
was subjected to a cyclic voltammetric scan between  0.5 and +0.65 V
(versus Pt pseudo-reference electrode) at a scan rate of 50 mV/s for three
times.
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Genome isolation. The sample containing E.coli or B.subtilis
or both (1 mL), which was cultured in Luria–Bertaini broth
overnight at 37 C, was mixed with 1 mL each of the biotiny-
lated genome capture probe (1 nM) for E.coli and B.subtilis
along with 7 mL of the SSC buffer. The mixture was injected
into the reaction chamber and sealed with Bostik’s Blu-Tack.
Then, the silicon–glass device was placed in a plexiglass
holder with contact pins for electrical connections to the
heater and temperature sensors (Figure 1C). The chamber
was maintained at 90 C for 5 min to lyse the cell and at
the same time denature the genomic DNAs. After that, the
temperature was cooled to 50 C and held for 10 min to
allow speciﬁc hybridization between the denatured genomic
DNAs and capture probes. Subsequently, 1 mL of the func-
tionalized magnetic particles were added into the chamber
and incubated for 10 min to capture the speciﬁc genomes
onto the magnetic particles. Finally, SSC buffer was used
to remove any unwanted materials with an external magnet
to keep the particles within the microchamber.
Asymmetric PCR. The PCR master mix consisted of 1· buffer
(20 mM Tris HCl, pH 8.4, 50 mM KCl), 2 mM MgCl2,
0.2 mM dNTPs, 200 nM of biotinylated E.coli forward primer
(50-biotin-GACAAGAAAATCTCCAACATCC-30), 2 nM of
E.coli reverse primer (50-ACAACACGTTTAGCCTGACC-30),
2n Mo fB.subtilis forward primer (50-CCTACGGGAGG-
CAGCAG-30), 200 nM of B.subtilis biotinylated reverse
primer (50-biotin-CCAGTTTCCAATGACCCTCCCC-30),
0.5 mg/mL BSA, and 0.4 U/mL Taq polymerase. The mixture
was pipetted into the microchamber and subjected to the fol-
lowing thermal cycling proﬁle: initial denaturation at 94 C
for 5 min; 40 cycles at 94 C for 30 s, at 60 C for 30 s,
72 C for 30 s; and ﬁnal extension at 72 C for 5 min.
Electrochemical amplicon detection. After the asymmetric
PCR, the solution was allowed to stand at room temperature
for 1 h. Unhybridized amplicons were washed away with
the SSC buffer. Gold nanoparticle label was bound to the
hybridized amplicons by exposing the electrode to a stre-
ptavidin gold nanoparticle (5 nm) solution (the stock was
diluted 10 times with 0.05 M 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid/0.2 M NaCl) for 30 min at
room temperature. The unbound gold nanoparticles were
removed by ﬂushing the microchamber with phosphate-
buffered nitrate solution (0.3 M NaNO3/10 mM sodium
phosphate, pH 7.0). Electrocatalytic silver deposition onto
the hybrid-bound gold nanoparticles was then achieved by
applying a potential of  0.18 V in a silver nitrate solution
(1 mM AgNO3/1 M KNO3) for 20 s. Finally, the amount of
deposited silver was determined by measuring the oxidative
silver dissolution response with an applied anodic current
of 10 mA in the same silver nitrate solution, and the time to
reach a potential of +0.65 V was taken as the signal.
RESULTS AND DISCUSSION
Oligonucleotide detection capture probe
immobilization
The single microchamber design poses particular challenges
to the electrochemical platform used for the sequence-speciﬁc
PCR amplicons detection. Addressability and compatibility
are two important considerations regarding immobilization
chemistry for the oligonucleotide detection capture probes.
For a multiplexed assay, it is necessary to individually mod-
ify the detection platform so that each individual electrode
in an electrode array has a speciﬁc capture probe. When
using either high temperature or ultra-violet glue to seal the
Figure 3. Fluorescence images of the four oligonucleotide-functionalized ITO electrodes (A and D: B.subtilis probe; B and C: E.coli probe) after exposure to a
fluorescein-labeled sequence complementary to the E.coli probe. Note that the electrodes are circular in shape.
e118 Nucleic Acids Research, 2006, Vol. 34, No. 18 PAGE 4 OF 7microchamber, it is recommended that immobilization should
be carried out after the silicon glass bonding process so as to
prevent damage to the capture probes. In doing so, the more
common chemical attachment (spotting) method cannot be
used because all the active electrode surfaces are embedded
within the same microchamber and they would receive ident-
ical modiﬁcations. One simple way to achieve site-speciﬁc
probe immobilization onto individual electrode surfaces can
Figure 4. A schematic representation of the assay protocol in the silicon glass microchamber. The three main steps were (A) sample preparation: thermal cell
lysis and magnetic particle-based isolation of specific genomic DNAs; (B) target DNA amplification: generation of single-stranded rich amplicons by asymmetric
PCR; (C) product detection: gold nanoparticle labeling, electrocatalytic silver deposition, and electrochemical silver dissolution.
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and pyrrole oligonucleotide (11). Figure 2 illustrates the
strategy to immobilize different capture probes onto each
individual electrode. A solution of pyrrole and oligonucleo-
tide 1 bearing a pyrrole group is introduced into the micro-
chamber. When a cyclic voltammetric scan is applied to
electrode 1, with other electrodes disconnected or grounded,
oligonucleotide 1 is selectively deposited on this particular
electrode. Then, the microchamber is washed with water to
ensure there is no pyrrole oligonucleotide 1 monomer is
left. This procedure is repeated for the other electrodes with
different pyrrole oligonucleotide polymerization solutions.
In our model system with two target analytes and four work-
ing electrodes, the capture probes speciﬁc to E.coli and
B.subtilis are immobilized in duplicate. Before proceeding
to the complete analytical protocol, the ability of these immo-
bilized capture probes to recognize their complementary tar-
gets should be tested. Figure 3 shows the ﬂuorescence images
of the four functionalized electrodes (A and D: B.subtilis
probe; B and C: E.coli probe) exposed to a sample containing
a ﬂuorescently-labeled sequence complementary to the E.coli
probe. It is clear that electrodes B and C exhibit much higher
ﬂuorescence intensity than electrodes A and D, indicating the
highly speciﬁc probe immobilization as well as hybridization
offered by the electrochemical pyrrole-based attachment
chemistry. Another criterion for the selection of immobil-
ization method is the compatibility with other processes, in
particular the PCR. Due to the fact that the detection elec-
trodes are within the reaction chamber, the linkage between
the immobilized capture probe and electrode surface must
be strong enough to survive through the thermal cycling
process (especially the high denaturation temperature). More-
over, the detector surface should interact only with the spe-
ciﬁc amplicon but not with other components employed in
the assay protocol.
Assay protocol
The assay procedure used in this work is schematically
represented in Figure 4. It involves three main steps: sample
preparation, target DNA ampliﬁcation, and product detection,
all performed within the same microchamber. Intact cells
are ﬁrst broken down by applying a high temperature
(90 C, controlled by the on-chip heater and temperature sen-
sor) to free the genomic DNA. To remove all the interfering
substances (e.g. cell debris and protein) that may affect the
subsequent DNA ampliﬁcation process, magnetic particles
are used to isolate the speciﬁc genomes. Biotinylated genome
capture probes for the two model species are mixed with
the intact cells before injecting into the microchamber.
When the temperature is lowered to 50 C after the thermal
lysis step, these probes hybridize to their complementary
target genomes. These probe genome hybrids are then iso-
lated by the addition of the avidin-coated magnetic particles,
followed by thorough washing. It is worth noting that the
magnetic particles are pretreated with a small amount of
the genome capture probes to minimize nonspeciﬁc adsorp-
tion of the interfering substances and other genomic DNAs.
Subsequently, with the genomes captured on the magnetic
particles serving as the template, asymmetric PCR is
conducted to generate single-stranded rich target amplicons.
After the ampliﬁcation step, these amplicons hybridize to
their corresponding detection electrodes. Next, the hybridized
amplicons are labeled with gold nanoparticles via biotin–
avidin interaction. Finally, silver metal is electrocatalytically
deposited onto the gold nanoparticles and the amount is
determined by the electrochemical oxidative dissolution tech-
nique (10,12). The detailed procedure for the sample pre-
paration, target DNA ampliﬁcation, and product detection
steps is given in the Materials and Methods section.
Performance evaluation of the microdevice
The ability of this single microchamber to detect speciﬁc cell
type using the above protocol is demonstrated by running
a series of experiments with E.coli cells of different concen-
trations, taking the signal from the B.subtilis detection cap-
ture probe-modiﬁed electrode as the background. Figure 5
gives a semi-log plot of the sample to background ratio
against the number of cells in the sample. A linear relation-
ship is obtained in the concentration range investigated
(10
2–10
5 cells/sample). This result conﬁrms the successful
isolation of the genome with the magnetic particle-based
approach, compatibility of the magnetic particle with the
PCR, thermal stability of the immobilized detection capture
probe through the temperature cycling process, as well as
negligible nonspeciﬁc adsorption on the electrode surface.
Another attractive feature of this microdevice is multi-
plexing. By constructing an electrode array, it is possible
to identify several species in a single run. The results for
the detection of the two model species are presented in
Figure 6. If the sample contains E.coli cells only, there is
a signiﬁcant increase in the analytical signal (silver metal
stripping time) for the E.coli detection capture probe-
functionalized electrode while that for the B.subtilis remains
the same as the background signal. When the sample contains
Figure 5. A calibration plot of the sample-to-background ratio against the
logarithmic number of E.coli cells in the sample. In our four working
electrode design, the silver stripping time to reach a potential of +0.65 V
(versus Pt pseudo-reference electrode) for the E.coli detection capture probe-
modified electrodes was taken as the sample signal whereas that for the
B.subtilis detection capture probe-modified electrodes was taken as the
background signal. Note that the number of cells stated was the amount being
introduced into the microchamber.
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electrodes are obtained. Another case is the inclusion of
both cell types; not surprisingly, both electrodes have much
higher signals than the background.
CONCLUSIONS
We have demonstrated the utilization of a silicon glass-
based microchamber for DNA-based detection of E.coli and
B.subtilis cells. Thermal cell lysis, magnetic particle-based
target genome isolation, DNA ampliﬁcation, and electro-
chemical sequence-speciﬁc amplicons detection have been
successfully implemented in this microdevice platform. The
portable electrochemical instrumentation as well as a simple
microchip design is conducive to the realization of on-site
pathogen detection. The selective immobilization of capture
probes using the pyrrole-based electropolymerization process
provides good thermal stability and PCR process compatibil-
ity, which are crucial for the multiplexed analysis. Future
work will be directed towards interfacing the microchip
with macro-world so as to achieve a fully automatic device
that can be used by untrained individuals.
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